Dr. Christopher F. Lobo, MD

Dr. Lobo practices at Florida Cancer Specialists & Research Institute - Cape Coral Cay West in North Port, Florida.

Dr. Lobo's NPI, 1073571949, was assigned on May 2, 2006. Dr. Lobo graduated from Royal College of Surgeons Ireland in 2000. Dr. Lobo holds Florida license ME89074.

Dr. Lobo's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West, at 1390 Grand Venture Dr, North Port, FL 34286 in Sarasota County. The practice phone is (239) 541-4633.

Dr. Lobo's primary practice is Florida Cancer Specialists & Research Institute - Cape Coral Cay West in North Port, Florida. Dr. Lobo is also affiliated with Sarasota Memorial Hospital - Sarasota Campus. The medical group on file is Florida Cancer Specialists & Research Institute. Dmand AI also links Dr. Lobo to 4 more hospitals and 1 group practice or clinic, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Lobo practices, 6 sites in all. Vendor and product names are available with a free account.

Medical oncology is Dr. Lobo's primary specialty in the NPI Registry, under taxonomy code 207RX0202X. Dr. Lobo is board certified in hematology by the American Board of Internal Medicine. Dr. Lobo is licensed in Florida.

Dmand AI lists breast cancer, chronic anemia, chronic embolism thrombosis, chronic leukemia, colorectal cancer, deep vein thrombosis (DVT), immune deficiency disease and lung cancer among the conditions Dr. Lobo treats.

CMS data shows 601,858 Medicare services from Dr. Lobo across 78 procedure codes in 2024, for 2,334 Medicare patients. Medicare paid $6,529,225 for them.

CMS counts 2,334 Medicare patients who saw Dr. Lobo in 2024. The largest group is 75 to 84, with 1,008 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 7% are also on Medicaid. Their average risk score is 2.21, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Lobo's median patient age at 74, with 55% women.

In 2024, Dr. Lobo wrote 3,156 Medicare Part D claims for 627 patients. 76% of them were for generic drugs. CMS names the drug for 2,728 of them, across 75 drugs with 11 or more claims each, at $6,806,354 in total drug cost. In 2023, CMS named 2,712 claims across 69 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 75 out of 100 for Dr. Lobo for performance year 2024, reported as part of a group. Dr. Lobo accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Dmand AI links 2 papers to Dr. Lobo, published from 2007 to 2010. The most frequent topics are Albumins, Antibodies, Monoclonal and Antibodies, Monoclonal, Humanized. Dr. Lobo's most frequent co-authors are Gilberto Lopes, MD, Aurelio B. Castrellon, MD and Judith Hurley, MD.

CMS Open Payments shows 537 general payments to Dr. Lobo from 65 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 99% of the total. Bristol-Myers Squibb Company paid the most, $1,104.

Dr. Lobo graduated from Royal College of Surgeons Ireland in 2000.

Dr. Lobo is in network with 19 carriers, including Elevance, Aetna and Excellus BlueCross BlueShield. PPO plans come from the most carriers, 13. Check the plan with the practice before a visit.